A strategy for identification of drug metabolites from dried blood spots using triple‐quadrupole/linear ion trap hybrid mass spectrometry
- 14 June 2005
- journal article
- research article
- Published by Wiley in Rapid Communications in Mass Spectrometry
- Vol. 19 (14), 1984-1992
- https://doi.org/10.1002/rcm.2013
Abstract
Discovery stage studies that address issues of absorption, distribution, metabolism and excretion (ADME) are vital for lead optimization resulting in new drug candidates. Often pharmacokinetics (PK) is assessed in these experiments without regard for the metabolism of the compound or the potential for metabolites to circulate in vivo. This work presents a strategy for drug level determination and detection of metabolites using dried blood spots for sample collection. Initially, metabolites are detected from microsomal incubations and characterized using tandem mass spectrometry. Data dependent enhanced MS and enhanced product ion (EMS-EPI) scanning with dynamic background subtraction was used on a hybrid quadruple linear ion trap mass spectrometer. On-the-fly background subtraction greatly improved the detection of metabolites. These data were used to build a multiple reaction monitoring (MRM) method for the parent and metabolites. MRM-EPI scanning was used to analyze the extracted dried blood spots from the PK study. Circulating metabolites were detected using MRM and their identities confirmed on the basis of fragment ion spectra collected simultaneously. The use of dried blood spots provides a means for re-analysis of PK samples for metabolite identification without the need for complex sample storage and preparation. Both parent compound and metabolite information can be collected in these studies, resulting in a savings of time and resources. Copyright © 2005 John Wiley & Sons, Ltd.This publication has 14 references indexed in Scilit:
- Q Trap MSPublished by Taylor & Francis Ltd ,2004
- Discovery stage pharmacokinetics using dried blood spotsJournal of Chromatography B, 2004
- USE OF A BENZYLOXY-SUBSTITUTED LACTONE CYCLOOXYGENASE-2 INHIBITOR AS A SELECTIVE FLUORESCENT PROBE FOR CYP3A ACTIVITY IN PRIMARY CULTURED RAT AND HUMAN HEPATOCYTESDrug Metabolism and Disposition, 2004
- High-performance liquid chromatographic method for the determination of quinine and 3-hydroxyquinine in blood samples dried on filter paperJournal of Chromatography B, 2003
- Liquid chromatography/atmospheric pressure ionization–mass spectrometry in drug metabolism studiesJournal of Mass Spectrometry, 2003
- Rapid screening and characterization of drug metabolites using a new quadrupole–linear ion trap mass spectrometerJournal of Mass Spectrometry, 2003
- Quantitative high‐throughput analysis of drugs in biological matrices by mass spectrometryMass Spectrometry Reviews, 2003
- Drug Metabolites in Safety TestingToxicology and Applied Pharmacology, 2002
- A new linear ion trap mass spectrometerRapid Communications in Mass Spectrometry, 2002
- Chemical Image Fusion. The Synergy of FT-NIR and Raman Mapping Microscopy To Enable a More Complete Visualization of Pharmaceutical FormulationsAnalytical Chemistry, 2001